RSHNRushNet, Inc.
Price Chart
Loading chart...
About RushNet, Inc. (RSHN)
RushNet, Inc. (RSHN) is a Diagnostics & Research company headquartered in Beverly Hills, CA, United States whose shares trade over-the-counter on the Pink tier.
heliosDX is a National Clinical Reference Laboratory offering High-Complexity Urine Drug Testing (UDT), Behavioral Drug Testing, Allergy Droplet Cards, Oral Fluids, Infectious Disease (PCR), and NGS Genetic Testing. We are contracted in 44 of the lower 48 states, and looking to expand our reach and capabilities. Always staying ahead of the curve, by continually investing in our infrastructure with the most efficient scientific proven instruments, and latest cutting edge software for patient and physician satisfaction. This allows heliosDX to provide physicians fast and accurate reporting meeting and exceeding industry benchmarks. We excel in patient and client care through physician designed panels that aid in testing compliance and reporting education.
Products and services
heliosDX is a National Clinical Reference Laboratory offering High-Complexity Urine Drug Testing (UDT), Behavioral Drug Testing, Allergy Droplet Cards, Oral Fluids, Infectious Disease (PCR), and NGS Genetic Testing. We are contracted in 44 of the lower 48 states, and looking to expand our reach and capabilities. Always staying ahead of the curve, by continually investing in our infrastructure with the most efficient scientific proven instruments, and latest cutting edge software for patient and physician satisfaction. This allows heliosDX to provide physicians fast and accurate reporting meeting and exceeding industry benchmarks. We excel in patient and client care through physician designed panels that aid in testing compliance and reporting education.
RSHN key facts
- Ticker symbol
- RSHN
- Market tier
- Pink
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Headquarters
- Beverly Hills, CA, United States
- Country of incorporation
- US
- Year of incorporation
- 2018
- Employees
- 1
- Estimated market cap
- $1.75M (as of Apr 15, 2025)
- Shares outstanding
- 8,768,427,509
- Reporting standard
- Alternative Reporting Standard
- Audit status
- Unaudited
- Fiscal year end
- 12/31
- Latest filing
- Quarterly Report (Mar 31, 2024)
RushNet, Inc. leadership
- Ambrose Okechukwu Egbuonu — President, CEO, Company Secretary
- Chris Russell — General Counsel
- Maurice Kemp — Administrator
- William Tynan — Consultant
- Frank lkechukwu Igwealor — Treasurer
Explore more: Diagnostics & Research stocks · Healthcare sector · Pink stocks · OTC stocks starting with R
Press Releases
Loading press releases...
Latest News
Loading news...
Key Statistics
Major Holders
Loading...
Loading modules...
AI-Powered Stock Analysis
Get a concise 600-word investment analysis for RushNet, Inc. (RSHN) prioritizing the most recent news and developments. Our AI focuses on today's breaking news first, then recent company developments, business updates, strategic initiatives, and current market positioning. Get the most relevant and current analysis available.
Still in beta - Please send feedback after generating your analysis to help us improve!
Smart investment analysis prioritizing breaking news, then recent company developments and strategic insights - completely free!
More Diagnostics & Research Companies on OTC Markets
Other OTC-traded companies in Diagnostics & Research:
Investor Reviews
Investor Reviews (0)
Loading reviews...
Company Profile
Loading company profile data...
Contact Information
Company Leadership
Company Officers
Social Media
Business Details
Stock Details
Loading modules...